We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 29, 2020

Long-Term Prognosis Is Associated With Residual Disease and Not Initial Nodal Status After Neoadjuvant Systemic Therapy

The British Journal of Surgery


Additional Info

Disclosure statements are available on the authors' profiles:

The British Journal of Surgery
Long-Term Prognosis Is Associated With Residual Disease After Neoadjuvant Systemic Therapy but Not With Initial Nodal Status
Br J Surg 2020 Sep 21;[EPub Ahead of Print], L Zetterlund, F Celebioglu, T Hatschek, J Frisell, J de Boniface

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading